Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
landgren
Nov 6, 2023, 03:22 |
Blog
C. Ola Landgren: The launching of a new computational oncology fellowship/post-doc opportunity
Quoting C. Ola Landgren, Leader of Experimental Therapeutics at Sylvester Comprehensive Cancer Center, on LinkedIn:…
Sep 5, 2023, 17:53 |
Insight
Ola Landgren: In this tweetorial, we delve into a groundbreaking study on multiple myeloma and the immune microenvironment.
Ola Landgren, Professor of Medicine, Chief of the Myeloma Division, and Leader of the Experimental…
May 24, 2024, 01:21 |
Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
May 14, 2024, 08:19 |
Insight
Myeloma Paper of the Day, May 13th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 10, 2024, 10:58 |
Blog
Francesco Maura: How Vk*MYC Mouse genomic evolution mimics the one observed in human myeloma
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center, shared a post on X: "New paper…
May 7, 2024, 15:56 |
Blog
Sylvester Comprehensive Cancer Center - Firefighter Cancer Initiative and David Perez' story
Sylvester Comprehensive Cancer Center shares a story of a firefighter diagnosed with multiple myeloma discussing…
May 3, 2024, 05:31 |
Blog
Francesco Maura: New papers on early intervention in smoldering myeloma
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center shared a thread on X: “New paper…
Apr 27, 2024, 07:10 |
Insight
,
Opinion
Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research
Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared…
Apr 13, 2024, 03:43 |
Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
Jan 27, 2024, 08:16 |
Insight
Stephen Nimer: Another important publication from Sylvester’s multiple myeloma team that will be practice changing!
Stephen Nimer, Director at Sylvester Comprehensive Cancer Center, recently shared a post by Sylvester Comprehensive…
1
2
All:
20
Posts:
11 - 20
TRANSiTION - Exclusive Train the Trainers Programme 2024
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Facebook
RSS Feed
Twitter
Linkedin
Youtube